3l1s: Revision history

21 February 2024

• curprev 10:1910:19, 21 February 2024 OCA talk contribs 5,359 bytes −1,348 No edit summary

17 July 2019

• curprev 11:1111:11, 17 July 2019 OCA talk contribs 6,707 bytes +133 No edit summary

1 November 2017

• curprev 08:4608:46, 1 November 2017 OCA talk contribs 6,574 bytes −8 No edit summary

7 February 2016

• curprev 10:0910:09, 7 February 2016 OCA talk contribs 6,582 bytes +71 No edit summary

24 December 2014

• curprev 14:1814:18, 24 December 2014 OCA talk contribs 6,511 bytes +2,812 No edit summary

18 December 2014

• curprev 14:4714:47, 18 December 2014 OCA talk contribs 3,699 bytes +18 No edit summary

4 April 2013

• curprev 20:0320:03, 4 April 2013 OCA talk contribs m 3,681 bytes 0 Protected "3l1s" [edit=sysop:move=sysop]
• curprev 20:0320:03, 4 April 2013 OCA talk contribs 3,681 bytes +2,224 No edit summary

10 September 2010

• curprev 09:2509:25, 10 September 2010 OCA talk contribs 1,457 bytes −20 No edit summary

3 March 2010

• curprev 13:5713:57, 3 March 2010 OCA talk contribs 1,477 bytes +1,179 No edit summary

3 February 2010

• curprev 07:1707:17, 3 February 2010 OCA talk contribs 298 bytes +24 No edit summary

23 December 2009

• curprev 07:2507:25, 23 December 2009 OCA talk contribs 274 bytes +274 New page: '''Unreleased structure''' The entry 3l1s is ON HOLD Authors: Ter Haar, E. Description: 3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK...